CoChat

The DOI matches its Crossref record; 74 of the 75 references it cites were found in a registry or an index, and 1 are not checked yet; none of the 45 sources its claims cite is checked for support yet.

Specificity and efficiency of tamoxifen-mediated Cre induction is equivalent regardless of age

Open access

Abstract

Temporally controlling Cre recombination through tamoxifen (Tam) induction has many advantages for biomedical research. Most studies report early post-natal/juvenile (<2 m.o.) Tam induction, but age-related neurodegeneration and aging studies can require Cre induction in older mice (>12 m.o.). While anecdotally reported as problematic, there are no published comparisons of Tam-mediated Cre induction at early and late ages. Here, microglial-specific Cx3cr1 creERT2 mice were crossed to a floxed NuTRAP reporter to compare Cre induction at early (3–6 m.o.) and late (20 m.o.) ages. Specificity and efficiency of microglial labeling at 21–22 m.o. were identical in mice induced with Tam at early and late ages. Age-related microglial translatomic changes were also similar regardless of Tam induction age. Each Cre and flox mouse line should be independently validated, however, these findings demonstrate that Tam-mediated Cre induction can be performed even into older mouse ages and should be generalizable to other inducible Cre models.

Checked 2026-11-19 · 1 reference not checked yet

Overview

CoChat Summary

TL;DR

In Cx3cr1creERT2;NuTRAP mice, tamoxifen-induced Cre labeling of microglia at 21–22 months was equally specific and efficient whether induced early (3–6 m.o.) or late (20 m.o.). Age-related microglial translatomic changes were also similar regardless of induction age.

Key findings

  • At 21–22 m.o., ~20% of cortical singlets were eGFP+ in both early (n = 6, 4 females, 2 males) and late (n = 7, 5 females, 2 males) induction groups; >95% of eGFP+ cells were CD11b/CD45 double-positive (~98% in the figure legend). Efficiency was ~90% eGFP+ among CD11b+CD45mid cells and ~60% among CD11b+CD45high cells, with no difference by induction age.
  • TRAP RNA-seq separated positive vs. input fractions in PCA component 1 (67.6% variance) but not by induction or collection age; microglial marker enrichment was equivalent across groups and correlated >0.97, while astrocyte, neuron, and oligodendrocyte markers were depleted.
  • Differential expression with aging (old early n = 7, old late n = 5, young early n = 5; one-way ANOVA, Benjamini-Hochberg q < 0.1, fold change >|1.25|) was highly correlated between old early and old late induction groups. GSEA showed enrichment of DAM, ARM, MgND, and WAM subtypes and depletion of homeostatic microglia, plus senescence/SASP enrichment, similarly at both induction ages.
  • Specific markers showed consistent age-related changes regardless of induction age: DAM markers increased, homeostatic markers decreased, senescence markers increased (p16Ink4a significantly, p19Arf less), and MHC-I genes B2m, H2-D1, H2-K1, H2-M3 and receptors Lilrb3, Lilrb4, Pilra increased.

Methods

  • Cx3cr1creERT2 mice (Jax 020940) were crossed to floxed NuTRAP mice (Jax 029899). Tamoxifen was injected IP at 100 mg/kg daily for five consecutive days in sunflower seed oil at early (3–6 m.o.) or late (20 m.o.) age; brains were collected at 21–22 m.o. (and at 4 m.o. for young TRAP-seq).
  • Cortex single-cell suspensions were analyzed by flow cytometry for CD11b/CD45/eGFP; hippocampal sections were immunostained for mCherry/CD11b/eGFP. Hippocampal TRAP isolation used anti-EGFP immunoprecipitation, followed by RNA-seq on an Illumina NovaSeq 6000.
  • RNA-seq analysis used DESeq2 normalization, one-way ANOVA with Benjamini-Hochberg correction (q < 0.1) and fold change >|1.25|, GSEA, and Ingenuity Pathway Analysis. Main RNA-seq groups were young early induction (n = 5 females), old early induction (n = 7 females), and old late induction (n = 5 females); a smaller male set included young n = 4, old-early n = 5, old-late n = 2.

Limitations

  • Stated: findings should be generalizable across Cre/ERT2 systems, but each Cre and floxed gene combination should be independently validated; mouse line-specific factors (e.g., cell type, size of flox construct) could alter results, and investigators should consider direct assessments of Cre recombination in addition to imaging, flow cytometry, and enrichment tests.
  • Stated/evident: the main molecular findings were in female mice; the male analysis was smaller (young n = 4, old-early n = 5, old-late n = 2) and showed no/limited differences with age of induction.
  • Evident: the late induction group had slightly higher fold changes, which the authors attribute to a possible batch effect driven by three samples collected together and to natural variability; no direct measurement of tamoxifen metabolites or half-life by age was performed in this study.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1016/j.isci.2023.108413

Cites

74 of 75 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Graphical abstract
Graphical abstract CC BY-NC-ND · PubMed Central
Figure 1 Cell labeling and efficiency are equivalent regardless of TAM induction age (A) Experimental design of early Tam induction (4–6 m.o.) and late Tam induction (20 m.o.) in Cx3cr1-NuTRAP mice followed by brain collection for both groups at 21–22 m.o. (B) Single cell suspensions generated by enzymatic and mechanical dissociation of half brain cortex were gated on eGFP+ singlets, with ∼20% observed in both young and old induction mice. (C) Of these eGFP+ singlets nearly all (∼98%) were double-positive for CD11b and CD45. (D) Further dividing this triple positive population (CD11b+/CD45+/EGFP+) into prototypical microglia (CD45mid/CD11b+) and other resident macrophages (CD45high/CD11b+) revealed equivalent populations. (E) Using the same data, the inverse analysis was performed to determine percentage of all cells CD11b+/CD45+, of which nearly all were eGFP+, the vast majority of which were CD11b+/CD45+/EGFP+. (F) ∼90% percent of CD11b+CD45mid singlets were eGFP+, indicative of high efficiency of Cre recombination for microglia in our model with both ages of Tam induction. Similar efficiency of recombination was observed at both ages of induction when analyzing %eGFP in CD45high/CD11b+ cells (putative macrophages). Data are presented as mean ± S.E.M.
Figure 1 Cell labeling and efficiency are equivalent regardless of TAM induction age (A) Experimental design of early Tam induction (4–6 m.o.) and late Tam induction (20 m.o.) in Cx3cr1-NuTRAP mice followed by brain collection for both groups at 21–22 m.o. (B) Single cell suspensions generated by enzymatic and mechanical dissociation of half brain cortex were gated on eGFP+ singlets, with ∼20% observed in both young and old induction mice. (C) Of these eGFP+ singlets nearly all (∼98%) were double-positive for CD11b and CD45. (D) Further dividing this triple positive population (CD11b+/CD45+/EGFP+) into prototypical microglia (CD45mid/CD11b+) and other resident macrophages (CD45high/CD11b+) revealed equivalent populations. (E) Using the same data, the inverse analysis was performed to determine percentage of all cells CD11b+/CD45+, of which nearly all were eGFP+, the vast majority of which were CD11b+/CD45+/EGFP+. (F) ∼90% percent of CD11b+CD45mid singlets were eGFP+, indicative of high efficiency of Cre recombination for microglia in our model with both ages of Tam induction. Similar efficiency of recombination was observed at both ages of induction when analyzing %eGFP in CD45high/CD11b+ cells (putative macrophages). Data are presented as mean ± S.E.M.CC BY-NC-ND · PubMed Central
Figure 2 DNA Recombination in the brain of old Cx3cr1-NuTRAP mice subjected to tamoxifen treatment during early and late life Cx3cr1-cre+ NuTRAP+(Cx3cr1-NuTRAP) mice were treated with Tam at 4–6 m.o. (early induction) or 20 m.o. (late induction). At 21–22 m.o., brains were harvested and processed for immunohistochemical analysis of microglial recombination. Frozen tissue sections were immunostained with antibodies against mCherry and CD11b. Representative confocal fluorescent microscopy images of sagittal brain sections show that unlike Cre negative counterparts (controls) (a–a’’), Cx3cr1-NuTRAP brains displayed colocalization of eGFP (green signal), mCherry (red signal), and CD11b (blue signal) following early (b–b’’) and late (c–c’’) Tam administration regimes. The area imaged for each sample encompasses the dentate gyrus of the hippocampus. The scale bar depicts 20 μm.
Figure 2 DNA Recombination in the brain of old Cx3cr1-NuTRAP mice subjected to tamoxifen treatment during early and late life Cx3cr1-cre+ NuTRAP+(Cx3cr1-NuTRAP) mice were treated with Tam at 4–6 m.o. (early induction) or 20 m.o. (late induction). At 21–22 m.o., brains were harvested and processed for immunohistochemical analysis of microglial recombination. Frozen tissue sections were immunostained with antibodies against mCherry and CD11b. Representative confocal fluorescent microscopy images of sagittal brain sections show that unlike Cre negative counterparts (controls) (a–a’’), Cx3cr1-NuTRAP brains displayed colocalization of eGFP (green signal), mCherry (red signal), and CD11b (blue signal) following early (b–b’’) and late (c–c’’) Tam administration regimes. The area imaged for each sample encompasses the dentate gyrus of the hippocampus. The scale bar depicts 20 μm.CC BY-NC-ND · PubMed Central
Figure 3 Translatomes from young and old inductions are equivalently enriched for microglial markers (A) Cx3cr1-NuTRAP mice were induced at 3–6 m.o. and collected at 4 m.o. or 21–22 m.o. or induced at 20 m.o. and collected at 21-22m.o. TRAP isolation was performed on hippocampal dissections and RNASeq profiles generated from Input and Positive fractions. (B) Translatome profiles separated in the first component between the Input and Positive fractions in the first component and to a degree between young and old mice in the 2nd component. (C) Assessment of CNS cell type markers derived from cell sorting and ribosomal profiling studies revealed an equivalent enrichment of microglial markers and depletion of markers for other cell types. (D) Correlation analysis of the union of marker lists demonstrated a high congruency of enrichment (fold change Positive fraction/Input fraction) across ages and ages of TAM induction. (E) Example marker gene enrichments/depletion for microglia, neuron, astrocyte, and oligodendrocyte markers. Data are presented as mean ± S.E.M.
Figure 3 Translatomes from young and old inductions are equivalently enriched for microglial markers (A) Cx3cr1-NuTRAP mice were induced at 3–6 m.o. and collected at 4 m.o. or 21–22 m.o. or induced at 20 m.o. and collected at 21-22m.o. TRAP isolation was performed on hippocampal dissections and RNASeq profiles generated from Input and Positive fractions. (B) Translatome profiles separated in the first component between the Input and Positive fractions in the first component and to a degree between young and old mice in the 2nd component. (C) Assessment of CNS cell type markers derived from cell sorting and ribosomal profiling studies revealed an equivalent enrichment of microglial markers and depletion of markers for other cell types. (D) Correlation analysis of the union of marker lists demonstrated a high congruency of enrichment (fold change Positive fraction/Input fraction) across ages and ages of TAM induction. (E) Example marker gene enrichments/depletion for microglia, neuron, astrocyte, and oligodendrocyte markers. Data are presented as mean ± S.E.M.CC BY-NC-ND · PubMed Central
Figure 4 Differentially expressed genes with age are equivalent for different ages of induction (A) Heatmap of differentially expressed genes comparing both old early induction and old late induction to young early induction mice. The heatmap demonstrates similarity in differential expression in both old groups, allowing for equivalent detection of age-related changes regardless of induction age. (B) Comparing the age-related fold changes of differentially expressed genes from the different induction ages correlate highly between both ages of induction. (C) Heatmap of the GSEA enrichment scores comparing enrichment of microglial phenotypic markers (Table S3, gene lists) by tamoxifen induction time (OL v YE) and age (OE v YE) in positive fractions. ∗p < 0.05 Kolmogorov-Smirnov Test. (D) GSEA enrichment plots comparing enrichment of senescence associated secretory phenotype (SASP) and senescence markers (Table S3). (E) Relative Z score from IPA for disease pathways, upstream regulators, and canonical pathways for age related changes with various induction ages showing no difference between the old mouse groups.
Figure 4 Differentially expressed genes with age are equivalent for different ages of induction (A) Heatmap of differentially expressed genes comparing both old early induction and old late induction to young early induction mice. The heatmap demonstrates similarity in differential expression in both old groups, allowing for equivalent detection of age-related changes regardless of induction age. (B) Comparing the age-related fold changes of differentially expressed genes from the different induction ages correlate highly between both ages of induction. (C) Heatmap of the GSEA enrichment scores comparing enrichment of microglial phenotypic markers (Table S3, gene lists) by tamoxifen induction time (OL v YE) and age (OE v YE) in positive fractions. ∗p < 0.05 Kolmogorov-Smirnov Test. (D) GSEA enrichment plots comparing enrichment of senescence associated secretory phenotype (SASP) and senescence markers (Table S3). (E) Relative Z score from IPA for disease pathways, upstream regulators, and canonical pathways for age related changes with various induction ages showing no difference between the old mouse groups.CC BY-NC-ND · PubMed Central
Figure 5 Enrichment of microglial RNA isolated from various ages of induction (A) Heatmap created from markers for DAMs demonstrating similar enrichment of individual genes for DAMs regardless of age of induction. (B) Heatmap for homeostatic microglia showing consistent downregulation in both old age groups. (C) Heatmap for senescence related genes were equivalently upregulated regardless of the age of Tam induction. (D) Boxplots showing the change with age in both groups of Cdkn2a and both of its isoforms, p19Arf and p16Ink4a. (E) Select genes of interest based on other microglial aging studies showing similar patterns of differential expression regardless of age of induction. Data are presented as mean ± S.E.M., One-Way ANOVA SNK post-hoc, ∗∗p < 0.01, ∗∗∗∗p < 0.0001.
Figure 5 Enrichment of microglial RNA isolated from various ages of induction (A) Heatmap created from markers for DAMs demonstrating similar enrichment of individual genes for DAMs regardless of age of induction. (B) Heatmap for homeostatic microglia showing consistent downregulation in both old age groups. (C) Heatmap for senescence related genes were equivalently upregulated regardless of the age of Tam induction. (D) Boxplots showing the change with age in both groups of Cdkn2a and both of its isoforms, p19Arf and p16Ink4a. (E) Select genes of interest based on other microglial aging studies showing similar patterns of differential expression regardless of age of induction. Data are presented as mean ± S.E.M., One-Way ANOVA SNK post-hoc, ∗∗p < 0.01, ∗∗∗∗p < 0.0001.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

0 Valid · 0 Not valid · 18 Not checked · 42 Own results and interpretations

24 more claims

Create a free account to see all 60 claims and to verify the 45 references still open.

See all claims — free account
  • It may state two separate claims as one. 17
  • Probably not a substantial claim. 20

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

4 of 4

Citations

Cites

Show all 72 references

Cited by

See all 10

Metadata

Authors
Kellogg, C. M., Pham, K., Ko, S., Cox, J. E. J., Machalinski, A. H., Stout, M. B., Sharpe, A. L., Beckstead, M. J., Chucair-Elliott, A. J., Ocañas, S. R., & Freeman, W. M.
Affiliations
  • Oklahoma Medical Research Foundation (US)
  • University of Oklahoma Health Sciences Center (US)
Corresponding author
Freeman, Willard M.
Venue
iScience
Publisher
Elsevier BV
Published
2023-12
Volume
26
Issue
12
Pages
108413
ISSN
2589-0042 (ISSN-L)
OpenAlex
W4388534274
Cited by
10
References
72
Citations by year
2026: 6 · 2025: 3 · 2024: 1
FWCI
1.03
Type
journal article
Language
en
Open access
Licence
Locations
  • iScience (publishedVersion, cc-by-nc-nd)
  • bioRxiv (Cold Spring Harbor Laboratory) (submittedVersion)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • PubMed Central (submittedVersion)
  • PubMed (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Institutes of Health
  • National Institute on Aging (F31AG064861, P30AG050911, R01AG059430, R21AG072811, T32AG052363)
  • NIH Office of the Director (DP5OD033443, I01BX003906, I01BX005396, IK6BX006033)
  • U.S. Department of Veterans Affairs
  • Biomedical Laboratory Research and Development, VA Office of Research and Development
Topics
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Animal Genetics and Reproduction
Keywords
tamoxifen, Cre recombination, CreERT2, microglia, CX3CR1, aging, neurodegeneration

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-11-19, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-19 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Specificity and efficiency of tamoxifen-mediated Cre induction is equivalent regardless of age. https://app.cochat.ai/papers/10.1016/j.isci.2023.108413
The paper
Kellogg, C. M., Pham, K., Ko, S., Cox, J. E. J., Machalinski, A. H., Stout, M. B., Sharpe, A. L., Beckstead, M. J., Chucair-Elliott, A. J., Ocañas, S. R., & Freeman, W. M. (2023). Specificity and efficiency of tamoxifen-mediated Cre induction is equivalent regardless of age. iScience. https://doi.org/10.1016/j.isci.2023.108413

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.